• Optum
• 09 Dec, 2022

Resident expert: Optum Rx Chief Pharmacy Officer, Michael Einodshofer As costly specialty medications continue to enter the market, “alternative funding” is pitched as a way for self-funded employers to make their employees and dependents eligible for “free” medications. Is this a sustainable solution? And what financial, clinical, and even legal risks does this approach entail?
Read more...